Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats

British Journal of Nutrition

Volumn 118, Issue 7, 2017, Pages 481-492

  Song, Jiao J ^a,b   Tian, Wen J ^a,b   Kwok, Lai Yu ^a,b   Wang, Ya L ^a,b   Shang, Yi N ^a,b   Menghe, Bilige ^a,b   Wang, Jun G ^a,b  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Gut microbiota; Hyperlipidaemia; Lactobacillus plantarum; Microencapsulation; Probiotics

Indexed keywords

BACTERIAL DNA; BILE ACID; CHOLESTEROL; RNA 16S; TRIACYLGLYCEROL;

ANIMAL; BACTERIAL COUNT; BLOOD; COLON; DISEASE MODEL; DNA SEQUENCE; FECES; HIGH THROUGHPUT SEQUENCING; HYPERLIPIDEMIAS; INTESTINE FLORA; ISOLATION AND PURIFICATION; LACTOBACILLUS PLANTARUM; LIPID DIET; MALE; METABOLISM; MICROBIOLOGY; RAT; WISTAR RAT;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; COLON; COLONY COUNT, MICROBIAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FECES; GASTROINTESTINAL MICROBIOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HYPERLIPIDEMIAS; LACTOBACILLUS PLANTARUM; MALE; RATS; RATS, WISTAR; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 85031678792     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114517002380     Document Type: Article

References (52)

1. Prakash S &Jones ML (2005) Artificial cell therapy: new strategies for the therapeutic delivery of live bacteria. J Biomed BIOTECHNOL 2005, 44-56.
2. Eckel RH, Grundy SM &Zimmet PZ (2005) The metabolic syndrome. Lancet 365, 1415-1428.
3. Sekirov I, Russell SL, Antunes LCM, et al. (2010) Gut microbiota in health and disease. Physiol Rev 90, 859-904.
4. Marchesi JR, Adams DH, Fava F, et al. (2016) The gut microbiota and host health: a new clinical frontier. Gut 65, 330-339.
5. Rooks MG &Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16, 341-352.
6. Homayouni A, Ehsani MR, Azizi A, et al. (2007) Effect of lecithin and calcium chloride solution on the microencapsulation process yield of calcium alginate beads. Iran Polym J 16, 597.
7. Anselmo AC, McHugh KJ, Webster J, et al. (2016) Layerby-layer encapsulation of probiotics for delivery to the microbiome. Adv Mater 28, 9486-9490.
8. Wang J, Zhang H, Chen X, et al. (2012) Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a highlipid diet. J Dairy Sci 95, 1645-1654.
9. Tian W, Song J, Wang Y, et al. (2015) Effect of different calcium salts and methods for triggering gelation on the characteristics of microencapsulated Lactobacillus plantarum LIP-1. RSC Adv 5, 73352-73362.
10. Zhang Y, Du R, Wang L, et al. (2010) The antioxidative effects of probiotic Lactobacillus casei Zhang on the hyperlipidemic rats. Eur Food Res Technol 231, 151-158.
11. Fu L, Niu B, Zhu Z, et al. (2012) CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150-3152.
12. Li W &Godzik A (2006) Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658-1659.
13. Wang Q, Garrity GM, Tiedje JM, et al. (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73, 5261-5267.
14. Tilg H &Kaser A (2011) Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 121, 2126-2132.
15. Scott KP, Antoine JM, Midtvedt T, et al. (2015) Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 26, 25877.
16. Delzenne NM, Neyrinck AM, Backhed F, et al. (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Eedocrinol 7, 639-646.
17. Chen D, Yang Z, Chen X, et al. (2015) Effect of Lactobacillus rhamnosus hsryfm 1301 on the gut microbiota and lipid metabolism in rats fed a high-fat diet. J Microb Biotech 25, 687-695.
18. Tomaro-Duchesneau C, Saha S, Malhotra M, et al. (2012) Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells, and other biopharmaceutics: current status and future directions. J Pharm 5, 236-248.
19. Ooi LG &Liong MT (2010) Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11, 2499-2522.
20. Park DY, Ahn YT, Park SH, et al. (2013) Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLOS ONE 8, e59470.
21. Wang J, Tang H, Zhang C, et al. (2015) Modulation of gut microbiota during probiotic-media ted attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9, 1-15.
22. Duncan SH, Lobley GE, Holtrop G, et al. (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obesity 32, 1720-1724.
23. Schwiertz A, Taras D, Schafer K, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195.
24. Jumpertz R, Le DS, Turnbaugh PJ, et al. (2011) Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94, 58-65.
25. Poggi M, Bastelica D, Gual P, et al. (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50, 1267-1276.
26. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents dietinduced obesity and insulin resistance. Diabetes 56, 1986-1998.
27. Lindberg AA, Weintraub A, Zahringer U, et al. (1990) Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 12, S133-S141.
28. Caesar R, Reigstad CS, Backhed HK, et al. (2012) Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 61, 1701-1707.
29. Ijssennagger N, van der Meer R &van Mil SW (2016) Sulfide as a mucus barrier-breaker in inflammatory bowel disease? Trends Mol Med 22, 190-199.
30. Lahti L, Salonen A, Kekkonen RA, et al. (2013) Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. Peer J 1, e32.
31. Ridlon JM, Kang DJ, Hylemon PB, et al. (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47, 241-259.
32. Jones BV, Begley M, Hill C, et al. (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 105, 13580-13585.
33. Blasco-Baque V, Coupe B, Fabre A, et al. (2017) Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice. Diabetologia 60, 690-700.
34. Manzoni P, Mostert M, Leonessa ML, et al. (2006) Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 42, 1735-1742.
35. Matsui N, Ito R, Nishimura E, et al. (2005) Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition 21, 594-601.
36. Armougom F, Henry M, Vialettes B, et al. (2009) Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 4, e7125.
37. Hu M &Yue X (2002) Screening and cholesterol-degrading mechanism of Lactobacillus plantarum LP1103. Food Sci 6, 048-054.
38. Guo CF &Li JY (2013) Hypocholesterolaemic action of Lactobacillus casei F0822 in rats fed a cholesterol-enriched diet. Int Dairy J 32, 144-149.
39. Wang L, Zhang J, Guo Z, et al. (2014) Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition 30, 776-783. e1.
40. Marcil V, Delvin E, Garofalo C, et al. (2003) Butyrate impairs lipid transport by inhibiting microsomal triglyceride transfer protein in Caco-2 cells. J Nutr 133, 2180-2183.
41. Nishina PM &Freedland RA (1990) Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J Nutr 120, 668-673.
42. Trautwein EA, Rieckhoff D, Erbersdobler HF, et al. (1998) Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 128, 1937-1943.
43. Stappenbeck TS, Hooper LV &Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99, 15451-15455.
44. Moore WE &Moore LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61, 3202-3207.
45. Zhong Y, Marungruang N, Fåk F, et al. (2015) Effects of two whole-grain barley varieties on caecal SCFA, gut microbiota and plasma inflammatory markers in rats consuming low-and high-fat diets. Br J Nutr 113, 1558-1570.
46. Everard A, Lazarevic V, Gaia N, et al. (2014) Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 8, 2116-2130.
47. Louis S, Tappu RM, Damms-Machado A, et al. (2016) Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLOS ONE 11, e0149564.
48. Rossi G, Pengo G, Caldin M, et al. (2014) Comparison of microbiological histological and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL# strains in dogs with idiopathic inflammatory bowel disease. PLOS ONE 9, e94699.
49. Jones-Hall YL, Kozik A &Nakatsu C (2015) Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. PLOS ONE 10, e0119441.
50. Labbe A, Ganopolsky JG, Martoni CJ, et al. (2014) Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes. PLOS ONE 9, e115175.
51. Palm NW, De Zoete MR, Cullen TW, et al. (2014) Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000-1010.
52. Jones SE &Versalovic J (2009) Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 9, 35.